Skip to main content
Premium Trial:

Request an Annual Quote

French Informatics Company IT.OMICS Licenses Data Miner to Galderna

NEW YORK, Oct. 19 (GenomeWeb News) - Bioinformatics company IT.OMICS has given French-Swiss drug maker Galderma access to its LSGraph data-mining technology.

 

LSGraph enables researchers to mine the functional relationships between all known genes, proteins, and chemical compounds in the scientific literature.

 

Galderma is the fifth drug maker to license the technology in the past six months. The other four were Aventis, UCB Pharma, Proskelia, and Genfit.

 

Financial terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more